Australia and the Asia Pacific are fast becoming the destination of choice for the over US$140 billion international biotech industry, with considerable research incentives, supportive regulatory environments and affordable trial costs available.

The importance of diversity in the boardroom has become increasingly relevant in recent years, not only due to evidence strongly supporting its managerial merits, but also due to societal trends towards greater inclusiveness.

In Australia, the outsourcing of company secretarial services has become big business over the past 10 years as more companies focus on the importance of strong, coherent corporate governance standards.